This is a limited company view. Sign up for a Free Trial to see everything.

Advancing novel, small molecule treatments targeting epigenetic mechanisms in tumor and immune cells for the benefit of patients.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Boston

Founded

2008

Employees

73

Stage

Late

Total funding

$204M

Last funding

2 years ago

Acquisitions

0

Growth score

-24

Mindshare score

-59

Scoring

Deals

Employee Growth

Use Constellation Pharmaceuticals's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Constellation Pharmaceuticals's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Purchasing/ Lab Manager
Associate Director of Automation
Scientist II
Scientist II
Senior Scientist II
Senior Scientist, Bioinformatics
Research Scientist
Staff Accountant
Scientist I
Senior Scientist
Vice President of Research
Vice President of Human Resources
Senior scientist II
Research Associate
Research Associate
Senior Scientist I
Research Associate,Biology
Chief Scientific Officer

Similar Companies

Arvinas

We are developing first-in-class protein degradation therapeutics to degrade & destroy disease-causing proteins via the body's own protein disposal system.
Series B|51 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes